The clinical therapeutic implications of the Scandinavian Simvastatin Survival Study

The American Journal of Cardiology
C A Dujovne

Abstract

This analysis of the Scandinavian Simvastatin Survival Study (4S) describes how the design, implementation, and results answer most questions or concerns of practicing physicians regarding practicality and advantages of blood cholesterol-lowering drug intervention in patients who already have coronary artery disease. The results demonstrated that a drug with the safety and efficacy profile of simvastatin, utilized as it would be in a physician's office, can improve mortality and morbidity in patients with existing coronary disease without important side effects, and reduce hospitalizations for patients with coronary heart disease.

References

Jun 6, 1994·The American Journal of Medicine·M H Davidson

❮ Previous
Next ❯

Citations

Mar 28, 2008·Current Atherosclerosis Reports·Maureen E Mays, Carlos A Dujovne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Related Papers

The American Journal of Cardiology
Keith G Tolman
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
H E Bays, C A Dujovne
Southern Medical Journal
Dena James Smith, Kenneth E Olive
© 2021 Meta ULC. All rights reserved